RESUMO
La hipertensión arterial (HTA) tras la edad, es el factor de riesgo más importante relacionado con el ictus, y más del 25% de los ictus son atribuibles a la hipertensión. Actualmente en España la prevalencia de HTA en el anciano es aproximadamente del 70%, lo que se traduce que en nuestro país existen más de 5 millones de hipertensos mayores de 65 años. Hoy día son numerosos los ensayos y metaanálisis que demuestran que el tratamiento antihipertensivo reduce claramente el riesgo de ictus en los sujetos ancianos y muy ancianos (≥80 años). No obstante, aún existen numerosas áreas de incertidumbre como son: cuándo iniciar el tratamiento antihipertensivo, hasta dónde bajar las cifras tensionales o cuál es el mejor antihipertensivo en la prevención del ictus en esta población, entre otros. En este artículo presentamos una revisión de las evidencias actuales en la prevención primaria del ictus del paciente mayor mediante el tratamiento de la HTA(AU)
After age, arterial hypertension (AHT) is the most significant risk factor associated with stroke, and accounts for more than 25% of all strokes. The prevalence of AHT in the elderly in Spain is approximately 70%, which means that there are more than 5 million people over 65 years-old with hypertension in our country. There are currently numerous trials and meta-analyses that demonstrate that antihypertensive treatment clearly reduces the risk of stroke in elderly, and very elderly (≥80 years) subjects. However there are many areas of uncertainty such as, for example, when to start antihypertensive treatment, to what level should the blood pressure be lowered, or what is the best antihypertensive in the prevention of stroke in this population. In this article we present a review of the current evidence in the prevention of stroke in the elderly patient by means of treatment of the AHT(AU)
Assuntos
Humanos , Masculino , Feminino , Idoso , Idoso de 80 Anos ou mais , Prevenção Primária/métodos , Prevenção Primária/tendências , Acidente Vascular Cerebral/epidemiologia , Acidente Vascular Cerebral/prevenção & controle , Hipertensão/complicações , Hipertensão/diagnóstico , Fatores de Risco , Anti-Hipertensivos/uso terapêutico , Prevenção Primária/organização & administração , Prevenção Primária/normas , Acidente Vascular Cerebral/complicações , Acidente Vascular Cerebral/reabilitação , Hipertensão/prevenção & controleRESUMO
After age, arterial hypertension (AHT) is the most significant risk factor associated with stroke, and accounts for more than 25% of all strokes. The prevalence of AHT in the elderly in Spain is approximately 70%, which means that there are more than 5 million people over 65 years-old with hypertension in our country. There are currently numerous trials and meta-analyses that demonstrate that antihypertensive treatment clearly reduces the risk of stroke in elderly, and very elderly (≥80 years) subjects. However there are many areas of uncertainty such as, for example, when to start antihypertensive treatment, to what level should the blood pressure be lowered, or what is the best antihypertensive in the prevention of stroke in this population. In this article we present a review of the current evidence in the prevention of stroke in the elderly patient by means of treatment of the AHT.
